Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Revenue

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹671 Cr₹623 Cr₹581 Cr₹510 Cr₹472 Cr

What is the latest Revenue of LINCOLN PHARMACEUTICALS ?

The latest Revenue ratio of LINCOLN PHARMACEUTICALS is ₹671 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹671 Cr
Mar2025₹623 Cr
Mar2024₹581 Cr
Mar2023₹510 Cr
Mar2022₹472 Cr

How is Revenue of LINCOLN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹671 Cr
7.67
Mar2025 ₹623 Cr
7.35
Mar2024 ₹581 Cr
13.76
Mar2023 ₹510 Cr
8.09
Mar2022 ₹472 Cr -

Compare Revenue of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,164.5 Cr -1.9% -5.2% 7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹112,205.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.9% 4% -7.6% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.9%

-5.2%

7.3%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses